A Rhabdomyoma Within a Multilocular Thymic Cyst in a p53-Null Mouse

被引:1
|
作者
Starost, M. F. [1 ]
Tsang, K. [2 ]
Zerfas, P. M. [1 ]
Stratakis, C. A. [2 ]
机构
[1] NIH, Div Vet Resources, Bethesda, MD 20892 USA
[2] NICHHD, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
genetically engineered mouse; multilocular cyst; myoid cell; p53; gene; thymus; ultrastructure; MYOID CELLS; THYMOMA; HYPERPLASIA; CARCINOMA; TUMOR; CATS; MICE; DOG;
D O I
10.1177/0300985809353175
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A 9-month-old p53-null female mouse was found dead in its cage. At necropsy, a large thymic mass encompassed the heart. Microscopically, the mass was composed of numerous varying-sized cysts lined with simple squamous epithelial cells to columnar ciliated cells. Also present within this mass was a large aggregate of loosely arranged fusiform-shaped cells. These cells also were found in smaller numbers in the connective tissue surrounding the cysts. The larger aggregate of fusiform cells was positive for desmin and S-100 and negative for smooth muscle actin. Electron microscopy revealed well-formed Z lines and I bands of skeletal muscle phenotype. A diagnosis of rhabdomyoma within a congenital multilocular thymic cyst was made. The thymus contains a small population of myoid cells, which should be taken in consideration when evaluating thymic tumors.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [1] Targeting p53-Null Neuroblastomas through RLIP76
    Singhal, Jyotsana
    Yadav, Sushma
    Nagaprashantha, Lokesh Dalasanur
    Vatsyayan, Rit
    Singhal, Sharad S.
    Awasthi, Sanjay
    CANCER PREVENTION RESEARCH, 2011, 4 (06) : 879 - 889
  • [2] Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
    Wang, Zebin
    Zheng, Yu
    Park, Hyun Jung
    Li, Jing
    Carr, Janai R.
    Chen, Yi-ju
    Kiefer, Megan M.
    Kopanja, Dragana
    Bagchi, Srilata
    Tyner, Angela L.
    Raychaudhuri, Pradip
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05) : 759 - 767
  • [3] Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1
    K Takahashi
    H Akiyama
    K Shimazaki
    C Uchida
    H Akiyama-Okunuki
    M Tomita
    M Fukumoto
    T Uchida
    Oncogene, 2007, 26 : 3835 - 3845
  • [4] Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1
    Takahashi, K.
    Akiyama, H.
    Shimazaki, K.
    Uchida, C.
    Akiyama-Okunuki, H.
    Tomita, M.
    Fukumoto, M.
    Uchida, T.
    ONCOGENE, 2007, 26 (26) : 3835 - 3845
  • [5] Induction of apoptosis by bleomycin in p53-null HL-60 leukemia cells
    Gimonet, D
    Landais, E
    Bobichon, H
    Coninx, P
    Liautaud-Roger, F
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (02) : 313 - 319
  • [6] Identification of Modulated Genes by Three Classes of Chemopreventive Agents at Preneoplastic Stages in a p53-Null Mouse Mammary Tumor Model
    Abba, Martin C.
    Hu, Yuhui
    Levy, Carla C.
    Gaddis, Sally
    Kittrell, Frances S.
    Hill, Jamal
    Bissonnette, Reid P.
    Brown, Powel H.
    Medina, Daniel
    Aldaz, C. Marcelo
    CANCER PREVENTION RESEARCH, 2009, 2 (02) : 175 - 184
  • [7] Genetic heterogeneity in p53-null leukemia increases transiently with spindle assembly checkpoint inhibition and is not rescued by p53
    Mai Wang
    Steven Phan
    Brandon H. Hayes
    Dennis E. Discher
    Chromosoma, 2024, 133 : 77 - 92
  • [8] FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy
    Katz, Sharyn I.
    Zhou, Lanlan
    Ferrara, Thomas A.
    Wang, Wenge
    Mayes, Patrick A.
    Smith, Charles D.
    El-Deiry, Wafik S.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (01) : 91 - 100
  • [9] Genetic heterogeneity in p53-null leukemia increases transiently with spindle assembly checkpoint inhibition and is not rescued by p53
    Wang, Mai
    Phan, Steven
    Hayes, Brandon H.
    Discher, Dennis E.
    CHROMOSOMA, 2024, 133 (01) : 77 - 92
  • [10] Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors
    Emerling, Brooke M.
    Hurov, Jonathan B.
    Poulogiannis, George
    Tsukazawa, Kazumi S.
    Choo-Wing, Rayman
    Wulf, Gerburg M.
    Bell, Eric L.
    Shim, Hye-Seok
    Lamia, Katja A.
    Rameh, Lucia E.
    Bellinger, Gary
    Sasaki, Atsuo T.
    Asara, John M.
    Yuan, Xin
    Bullock, Andrea
    DeNicola, Gina M.
    Song, Jiaxi
    Brown, Victoria
    Signoretti, Sabina
    Cantley, Lewis C.
    CELL, 2013, 155 (04) : 844 - 857